Axenfeld-Rieger syndrome (ARS) is a clinically and genetically heterogeneous group of autosomal dominantly inherited malformations that predominantly affect the eye but are also associated with craniofacial dysmorphism and dental abnormalities. A broad spectrum of genetic alterations involving PITX2 and FOXC1 lead to ARS. We report on a 4-year-old girl with clinical features of ARS and developmental delay due to a de novo apparently balanced pericentric inversion in chromosome 4. This report emphasizes that complementary investigations are necessary to precisely characterize chromosomal rearrangements. Elucidation of the exact genetic cause of ARS is important for comprehensive genetic counseling of the family members and for better patient management.

Keywords:
Axenfeld-Rieger syndrome, Deletion 4p15.2, Intellectual disability, Pericentric inversion, PITX2
1.
Alward WLM, Semina EV, Kalenak JW, Heón E, Sheth BP, Stone EM, Murray JC: Autosomal dominant iris hypoplasia is caused by a mutation in the Rieger syndrome (RIEG/PITX2) gene. Am J Ophthalmol 125:98-100 (1998).
2.
Doward W, Perveen R, Lloyd IC, Ridgway AEA, Wilson L, Black GCM: A mutation in the RIEG1 gene associated with Peters' anomaly. J Med Genet 36:152-155 (1999).
3.
Engenheiro E, Saraiva J, Carreira I, Ramos L, Ropers HH, et al: Cytogenetically invisible microdeletions involving PITX2 in Rieger syndrome. Clin Genet 72:464-470 (2007).
4.
Evans AL, Gage PJ: Expression of the homeobox gene Pitx2 in neural crest is required for optic stalk and ocular anterior segment development. Hum Mol Genet 14:3347-3359 (2005).
5.
Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, et al: 2009. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum Genet 84:524-533 (2009).
6.
Footz T, Idrees F, Acharya M, Kozlowski K, Walter MA: Analysis of mutations of the PITX2 transcription factor found in patients with Axenfeld-Rieger syndrome. Invest Ophthalmol Vis Sci 50:2599-2606 (2009).
7.
Huang N, Lee I, Marcotte EM, Hurles ME: Characterising and predicting haploinsufficiency in the human genome. PLoS Genet 6:e1001154 (2010).
8.
Idrees F, Vaideanu D, Fraser SG, Sowden JC, Khaw PT: A review of anterior segment dysgeneses. Surv Ophthalmol 51:213-231 (2006).
9.
Jacobs PA, Browne C, Gregson N, Joyce C, White H: Estimates of the frequency of chromosome abnormalities detectable in unselected newborns using moderate levels of banding. J Med Genet 29:103-108 (1992).
10.
Kamnasaran D, O'Brien PC, Zackai EH, Muenke M, Ferguson-Smith MA, Cox DW: 2003. Rearrangement in the PITX2 and MIPOL1 genes in a patient with a t(4;14) chromosome. Eur J Hum Genet 11:315-324 (2003).
11.
Kleinjan DA, van Heyningen V: Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet 76:8-32 (2005).
12.
Landrum MJ, Lee JM, Benson M, Brown G, Chao C, et al: 2016. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res 44(D1):D862-868 (2016).
13.
Lines MA, Kozlowski K, Kulak SC, Allingham RR, Héon E, et al: Characterization and prevalence of PITX2 microdeletions and mutations in Axenfeld-Rieger malformations. Invest Ophthalmol Vis Sci 45:828-833 (2004).
14.
McGowan-Jordan J, Simons A, Schmid M (eds): ISCN 2016: an international system for human cytogenetic nomenclature. Cytogenet Genome Res 149:1-140 (2016).
15.
Phillips JC, del Bono EA, Haines JL, Pralea AM, Cohen JS, et al: A second locus for Rieger syndrome maps to chromosome 13q14. Am J Hum Genet 59:613-619 (1996).
16.
Shields MB: Axenfeld-Rieger syndrome: a theory of mechanism and distinctions from the iridocorneal endothelial syndrome. Trans Am Ophthalmol Soc 81:736-784 (1983).
17.
Tabet AC, Verloes A, Pilorge M, Delaby E, Delorme R, et al: Complex nature of apparently balanced chromosomal rearrangements in patients with autism spectrum disorder. Mol Autism 6:19 (2015).
18.
Tanwar M, Kumar R, Goyal A, Kumar M, Dada T, et al: Rieger syndrome with multiple chromosomal breaks and chromosome 4 deletion. BMJ Case Rep 2009:bcr06.2008.0297 (2009).
19.
Trembath DG, Semina EV, Jones DH, Patil SR, Qian Q, et al: Analysis of two translocation breakpoints and identification of a negative regulatory element in patients with Rieger's syndrome. Birth Defects Res A Clin Mol Teratol 70:82-91 (2004).
20.
Tümer Z, Bach-Holm D: Axenfeld-Rieger syndrome and spectrum of PITX2 and FOXC1 mutations. Eur J Hum Genet 17:1527-1539 (2009).
21.
Werner W, Kraft S, Callen DF, Bartsch O, Hinkel GK: A small deletion of 16q23.1→16q24.2 [del(16)(q23.1q24.2).ish del(16)(q23.1q24.2)(D16S395+, D16S348−, P5432+)] in a boy with iris coloboma and minor anomalies. Am J Med Genet 70:371-376 (1997).
22.
Xia K, Wu L, Liu X, Xi X, Liang D, et al: Mutation in PITX2 is associated with ring dermoid of the cornea. J Med Genet 41:e129 (2004).
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.